StockData
Revvity, Inc. logo

Revvity, Inc. (RVTY) stock

RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29
Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3042% above fair value
$147.79−1.06 (-0.71%)

Close on Nov 17, 2026Market cap $16.49BP/E 70.4Yield 0.19%

Revvity r&d expenses

Research and development expenses are spending on new products and technology.

Revvity's R&D Expenses for the twelve months ending Jul 5, 2026 was $215.83M, up 5.2% year over year. For fiscal 2025 it was $215.84M, up 9.7% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $221.62M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 28, 2025$215.84M+9.7%
FY2024Dec 29, 2024$196.84M-9.1%
FY2023Dec 31, 2023$216.58M-2.3%
FY2022Jan 1, 2023$221.62M+10.6%
FY2021Jan 2, 2022$200.34M+36.8%
FY2020Jan 3, 2021$146.44M-22.7%
FY2019Dec 29, 2019$189.34M-2.4%
FY2018Dec 30, 2018$194.00M+39.1%
FY2017Dec 31, 2017$139.46M+12.3%
FY2016Jan 1, 2017$124.18M+10.3%
FY2015Jan 3, 2016$112.54M+4.1%
FY2014Dec 28, 2014$108.06M-18.4%
FY2013Dec 29, 2013$132.40M+0.4%
FY2012Dec 30, 2012$131.84M+13.8%
FY2011Jan 1, 2012$115.82M+22.2%
FY2010Jan 2, 2011$94.81M+4.8%
FY2009Jan 3, 2010$90.49M-2.7%
FY2008Dec 28, 2008$93.03M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 5, 2026$48.97M-8.1%
Q1 FY2026Apr 5, 2026$57.89M+8.0%
Q4 FY2025Dec 28, 2025$58.18M+18.2%
Q3 FY2025Sep 28, 2025$50.80M+3.4%
Q2 FY2025Jun 29, 2025$53.27M+10.7%
Q1 FY2025Mar 30, 2025$53.60M+6.4%
Q4 FY2024Dec 29, 2024$49.21M-0.8%
Q3 FY2024Sep 29, 2024$49.14M-7.3%
Q2 FY2024Jun 30, 2024$48.13M-15.9%
Q1 FY2024Mar 31, 2024$50.36M-11.2%
Q4 FY2023Dec 31, 2023$49.60M-9.1%
Q3 FY2023Oct 1, 2023$53.04M-0.9%
Q2 FY2023Jul 2, 2023$57.25M+2.2%
Q1 FY2023Apr 2, 2023$56.69M-1.4%
Q4 FY2022Jan 1, 2023$54.54M-10.0%
Q3 FY2022Oct 2, 2022$53.52M+8.3%
Q2 FY2022Jul 3, 2022$56.04M-14.9%
Q1 FY2022Apr 3, 2022$57.52M-4.5%
Q4 FY2021Jan 2, 2022$60.58M+6.6%
Q3 FY2021Oct 3, 2021$49.42M-1.4%
Q2 FY2021Jul 4, 2021$65.82M+32.9%
Q1 FY2021Apr 4, 2021$60.22M+23.1%
Q4 FY2020Jan 3, 2021$56.82M+19.3%
Q3 FY2020Oct 4, 2020$50.13M+10.5%
Q2 FY2020Jul 5, 2020$49.52M+2.4%
Q1 FY2020Apr 5, 2020$48.91M+1.9%
Q4 FY2019Dec 29, 2019$47.64M-8.3%
Q3 FY2019Sep 29, 2019$45.38M-7.1%
Q2 FY2019Jun 30, 2019$48.34M+2.4%
Q1 FY2019Mar 31, 2019$47.98M+4.3%
Q4 FY2018Dec 30, 2018$51.97M+37.7%
Q3 FY2018Sep 30, 2018$48.85M+40.0%
Q2 FY2018Jul 1, 2018$47.20M+40.6%
Q1 FY2018Apr 1, 2018$45.98M+38.1%
Q4 FY2017Dec 31, 2017$37.73M+14.9%
Q3 FY2017Oct 1, 2017$34.89M+18.2%
Q2 FY2017Jul 2, 2017$33.56M–
Q1 FY2017Apr 2, 2017$33.29M–
Q4 FY2016Jan 1, 2017$32.83M–
Q3 FY2016Oct 2, 2016$29.51M–

More Revvity figures

See a number that looks wrong?